Anti-VEGF(anti-vascular endothelial growth factor)-Therapie bei Zentralvenenverschluss in der Stillzeit
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2731-7218
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-VEGF(anti-vascular endothelial growth factor)-Therapie bei Zentralvenenverschluss in der Stillzeit ; day:20 ; month:7 ; year:2022 ; pages:1-4
Die Ophthalmologie ; (20.7.2022), 1-4
- Keyword
-
Deutschland
- Creator
-
Groselli, S.
Bechstein, L.
Gabka, K.
Ulbig, M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00347-022-01694-4
- URN
-
urn:nbn:de:101:1-2022100421502077819173
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Groselli, S.
- Bechstein, L.
- Gabka, K.
- Ulbig, M.
- SpringerLink (Online service)
Other Objects (12)
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
Anti-VEGF : 13 tables
Auswertung der Zweijahresdaten zur intravitrealen Therapie mittels Anti-VEGF (Vascular Endothelial Growth Factor) bei Makulaödem nach retinalen Venenverschlüssen
Langzeitverlauf von makulären Neovaskularisationen bei chorioidalen Osteomen mit und ohne intravitreale Anti-VEGF(vascular endothelial growth factor)-Therapie
Anti-VEGF-Therapie unter Entzündungsparametern : Aufnahme und intrazellulärer Transport der Anti-VEGF-Substanzen
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
Expression des Vascular Endothelial Growth Factor [VEGF] in kolorektalen Karzinomen
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
Anti-VEGF : 13 tables
Auswertung der Zweijahresdaten zur intravitrealen Therapie mittels Anti-VEGF (Vascular Endothelial Growth Factor) bei Makulaödem nach retinalen Venenverschlüssen
Langzeitverlauf von makulären Neovaskularisationen bei chorioidalen Osteomen mit und ohne intravitreale Anti-VEGF(vascular endothelial growth factor)-Therapie
Anti-VEGF-Therapie unter Entzündungsparametern : Aufnahme und intrazellulärer Transport der Anti-VEGF-Substanzen
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
Expression des Vascular Endothelial Growth Factor [VEGF] in kolorektalen Karzinomen
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
Anti-VEGF : 13 tables
Auswertung der Zweijahresdaten zur intravitrealen Therapie mittels Anti-VEGF (Vascular Endothelial Growth Factor) bei Makulaödem nach retinalen Venenverschlüssen
Langzeitverlauf von makulären Neovaskularisationen bei chorioidalen Osteomen mit und ohne intravitreale Anti-VEGF(vascular endothelial growth factor)-Therapie
Anti-VEGF-Therapie unter Entzündungsparametern : Aufnahme und intrazellulärer Transport der Anti-VEGF-Substanzen
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma